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Research
Recent data indicate an alarming increase in 
the incidence of neurodevelopmental disor-
ders [for review, see Grandjean and Landrigan 
2006; Landrigan et al. 1994; Szpir 2006a, 
2006b; Weiss et al. 2004; Weiss and Bellinger 
2006)], currently involving up to 17% of 
U.S. school children, including attention 
deficit hyper  activity disorder, learning dis-
abilities, and autism spectrum disorders, at an 
annual cost of $80–170 billion (Szpir 2006a, 
2006b). Exposures to environmental chemi-
cals are strongly suspected to play a key role 
in these increases, contributing to what has 
been termed a “silent pandemic” (Grandjean 
and Landrigan 2006). Given that thousands 
of new chemicals are introduced each year, 
most of which are untested for developmental 
neurotoxicity, it seems unlikely that exposures 
to such toxicants will decline. Accordingly, 
we already have a legacy of millions of chil-
dren with environmentally related neuro-
developmental disorders, and we can expect 
this problem to continue or even increase. 
Toxicologic research most often focuses on the 
identification of specific toxicants and their 
mechanisms of action, but it is equally valid to 
examine whether subsequent interventions can 
offset or ameliorate the consequences of expo-
sure. In our previous work, we showed how 
identification of specific neuro  transmitter or 
signaling pathways affected by diverse neuro-
toxicants can lead to therapies that restore 
both synaptic and behavioral function (Beer 
et al. 2005; Izrael et al. 2004; Shahak et al. 
2003; Slotkin et al. 2001b; Steingart et al. 
2000a, 2000b; Yanai et al. 2002, 2004, 2005); 
in particular, we were able to repair deficient 
function of acetylcholine (ACh) projections 
in the hippo  campus by transplanting neural 
progenitor cells or to achieve pharmacologic 
reversal of symptoms by chronic treatment 
with ACh receptor agonists.
Here, we focus on a strategy that may be 
more readily applicable to neuro  develop  mental 
disorders, namely dietary manipulation in 
which the majority of calories are derived from 
fat (i.e., a “ketogenic” diet). This approach 
has met with some success in drug-resistant 
childhood epilepsies, although the specific 
mechanism for the improvement is unknown 
(Bough and Rho 2007; Connolly et al. 2006; 
Hallbook et al. 2007; Hartman and Vining 
2007). Interestingly, the same approach has 
been tried in treating attention deficit hyper-
activity disorder and autism in pilot studies 
(Connolly et al. 2006; Evangeliou et al. 2003; 
Pulsifer et al. 2001), again with some evi-
dence of success. However, it must be noted 
that such trials obviously cannot be blinded 
because the diet is altered in a way known to 
the subject. A few animal studies examined 
the effects of a high-fat diet on neural func-
tion, providing some evidence for a general-
ized decrease in excitability and reduced motor 
activity (Murphy and Burnham 2006; Murphy 
et al. 2005); notably, in keeping with the pilot 
human studies, high fat diets ameliorate behav-
ioral anomalies in genetically modified mice 
(Teegarden et al. 2008). The ability of dietary 
manipulations to evoke widespread changes 
in neuro  transmitter function is likely due to 
changes in the composition of membrane 
lipids in which receptors and cell signaling 
molecules are embedded (Gudbjarnason and 
Benediktsdottir 1996; Ponsard et al. 1999) and 
therefore can span multiple brain regions and 
neurotransmitter systems. Indeed, diet-induced 
changes in neural membrane lipids are known 
to alter neuro  transmitter uptake and release, as 
well as function of neurotransmitter receptors 
and their signaling pathways (Clandinin et al. 
1983; Geiser 1990; Kelly et al. 1995). 
In the present study, we present a “proof 
of principle” by evaluating the ability of a 
high-fat diet to reverse the ACh-related synap-
tic abnormalities evoked by neo  natal exposure 
to an organophosphate pesticide, parathion. 
Organophosphates are the most widely used 
insecticides (Casida and Quistad 2004) and 
human exposures are virtually ubiquitous 
(Casida and Quistad 2004; Morgan et al. 
2005). These agents are under  going increased 
scrutiny specifically because of their propensity 
to elicit developmental neuro  toxicity at levels 
below those required for any signs of systemic 
exposure (Colborn 2006; Costa 2006; Pope 
1999; Slotkin 2004, 2005). Here, we evalu-
ated the effects of a brief neonatal parathion 
exposure at doses straddling the threshold for 
cholinesterase inhibition and the first signs of 
toxicity (Slotkin et al. 2006a). In adulthood, we 
switched some of the animals to a ketogenic, 
high-fat diet that more than doubles serum 
β-hydroxybutyrate concentrations (Lassiter 
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Ba c k g r o u n d: Developmental exposure to a wide variety of developmental neurotoxicants, including 
organophosphate pesticides, evokes late-emerging and persistent abnormalities in acetylcholine (ACh) 
systems. We are seeking interventions that can ameliorate or reverse the effects later in life.
oBjectives: We administered parathion to neonatal rats and then evaluated whether a high-fat diet 
begun in adulthood could reverse the effects on ACh systems. 
me t h o d s : Neonatal rats received parathion on postnatal days 1–4 at 0.1 or 0.2 mg/kg/day, strad-
dling the cholinesterase inhibition threshold. In adulthood, half the animals were switched to a 
high-fat diet for 8 weeks. We assessed three indices of ACh synaptic function: nicotinic ACh recep-
tor binding, choline acetyltransferase activity, and hemicholinium-3 binding. Determinations were 
performed in brain regions comprising all the major ACh projections and cell bodies.
re s u l t s: Neonatal parathion exposure evoked widespread abnormalities in ACh synaptic markers, 
encompassing effects in brain regions possessing ACh projections and ACh cell bodies. In gen-
eral, males were affected more than females. Of 17 regional ACh marker abnormalities (10 male, 
7 female), 15 were reversed by the high-fat diet.
co n c l u s i o n s: A high-fat diet reverses neurodevelopmental effects of neonatal parathion exposure 
on ACh systems. This points to the potential for nonpharmacologic interventions to offset the effects 
of developmental neurotoxicants. Further, cryptic neurodevelopmental deficits evoked by environ-
mental exposures may thus engender a later preference for a high-fat diet to maintain normal ACh 
function, ultimately contributing to obesity.
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et al. 2008). We performed assessments in brain 
regions encompassing major ACh projections 
as well as those containing the corresponding 
cell bodies, focusing on three markers of ACh 
synaptic function that are targeted by develop-
mental exposure to parathion and that contrib-
ute to ACh-related behavioral impairment by 
organophosphates (Slotkin et al. 2006a, 2007a, 
2008b; Timofeeva et al. 2008b): activity of cho-
line acetyltransferase (ChAT), cell membrane 
binding of hemi  cholinium-3 (HC3) to the 
presynaptic high-affinity choline transporter, 
and the concentration of α4β2 nicotinic ACh 
receptors (nAChRs). ChAT is the enzyme that 
synthesizes ACh and, because it is a constitutive 
component of ACh nerve terminals, its activ-
ity provides an index of the development of 
ACh projections (Dam et al. 1999; Happe and 
Murrin 1992; Monnet-Tschudi et al. 2000; 
Qiao et al. 2003; Richardson and Chambers 
2005; Slotkin et al. 2001a). Although HC3 
binding to the choline transporter is also a 
constituent of ACh nerve terminals, its expres-
sion is directly responsive to neuronal activity 
(Klemm and Kuhar 1979; Simon et al. 1976), 
so that comparative effects on HC3 binding 
and ChAT enables the characterization of both 
the development of innervation and presynaptic 
activity. Last, the α4β2 nAChR is a key player 
in the ability of ACh systems to release other 
neuro  transmitters involved in reward, cogni-
tion, and mood (Buisson and Bertrand 2001, 
2002; Dani and De Biasi 2001; Fenster et al. 
1999; Quick and Lester 2002) and is also the 
most abundant nAChR subtype in the mam-
malian brain (Flores et al. 1992; Happe et al. 
1994; Whiting and Lindstrom 1987, 1988).
Materials and Methods
Animal treatments and diet. All experiments 
were carried out humanely and with regard 
for alleviation of suffering, with protocols 
approved by the Duke University Institutional 
Animal Care and Use Committee and in 
accordance with all federal and state guide-
lines. Timed-pregnant Sprague-Dawley rats 
(Charles River, Raleigh, NC) were housed in 
breeding cages, with a 12 hr light–dark cycle 
and free access to water and food (LabDiet 
5001; PMI Nutrition, St. Louis, MO). On the 
day after birth, all pups were randomized and 
redistributed to the dams with a litter size of 
10 (5 males, 5 females) to maintain a standard 
nutritional status. Parathion (99.2% purity; 
Chem Service, West Chester, PA) was dis-
solved in DMSO to provide consistent absorp-
tion (Slotkin et al. 2006a, 2006b; Whitney 
et al. 1995) and was injected subcutaneously 
in a volume of 1 mL/kg once daily on post-
natal days 1–4; control animals received equiv-
alent injections of the DMSO vehicle. Doses 
of 0.1 and 0.2 mg/kg/day were chosen because 
they straddle the threshold for barely detect-
able cholinesterase inhibition and the first signs 
of reduced weight gain or impaired viability 
(Slotkin et al. 2006a, 2006b). Brain cholin-
esterase inhibition 24 hr after the last dose of 
0.1 mg/kg parathion is reduced 5–10%, well 
below the 70% threshold necessary for symp-
toms of cholinergic hyperstimulation (Clegg 
and van Gemert 1999). Randomization of 
pup litter assignments within treatment groups 
was repeated at intervals of several days up 
until weaning; in addition, dams were rotated 
among litters to distribute any maternal care-
taking differences randomly across litters and 
treatment groups. Offspring were weaned on 
postnatal day 21.
Beginning at 15 weeks of age, half the rats 
were switched to a high-fat diet (OpenSource 
D12330; Research Diets Inc., New Brunswick, 
NJ), providing 58% of total calories as fat; 
93% of the fat is hydrogenated coconut oil. 
The remaining rats continued on the standard 
LabDiet 5001 diet, which provides 13.5% 
of total calories as fat; with this diet, 27% of 
the fat is saturated. Although the high-fat 
diet contains 37% more calories per gram, 
we found that animals on this diet reduced 
their food intake by approximately the same 
proportion (Lassiter et al. 2008), so the 
total dietary intake is isocaloric; never  the-
less, animals gained excess weight because of 
the higher fat content (Lassiter et al. 2008). 
During the 24th post  natal week, animals were 
decapitated and brains were dissected into 
the frontal/parietal cortex, temporal/occipital 
cortex, hippo  campus, striatum, mid  brain, and 
brain  stem. Neurochemical determinations 
were made on regions from six rats per treat-
ment group for each sex and with each diet, 
with no more than one male and one female 
derived from a given litter in each group.
Assays. Tissues were thawed in 79 volumes 
of ice-cold 10 mM sodium-potassium phos-
phate buffer (pH 7.4) and homogenized with a 
Polytron (Brinkmann Instruments, Westbury, 
NY). Duplicate aliquots of the homogenate 
were assayed for ChAT using established pro-
cedures (Qiao et al. 2003, 2004). Each tube 
contained 50 µM [14C]acetyl-coenzyme A 
(specific activity 6.7 mCi/mmol; PerkinElmer 
Life Sciences, Boston, MA) as a substrate, 
and activity was determined as the amount of 
labeled ACh produced relative to tissue pro-
tein (Smith et al. 1985).
For measurements of HC3 binding, the 
cell membrane fraction was prepared from 
an aliquot of the same tissue homogenate by 
sedimentation at 40,000 × g for 15 min. The 
pellet was resuspended and washed, and the 
resultant pellet was assayed by established 
procedures (Qiao et al. 2003, 2004), using 
a ligand concentration of 2 nM [3H]HC3 
(specific activity, 125 Ci/mmol; PerkinElmer) 
with or without 10 µM unlabeled HC3 
(Sigma Chemical Co., St. Louis, MO) to 
displace specific binding. Determinations 
of nAChR binding were carried out in 
another aliquot, each assay containing 1 nM 
[3H]cytisine (specific activity 35 Ci/mmol; 
PerkinElmer) with or without 10 µM nicotine 
(Sigma) to displace specific binding (Slotkin 
et al. 2008a). Binding was calculated relative 
to the membrane protein concentration.
Data analysis. Data were compiled 
as means ± SE. Because we evaluated three 
neuro  chemical measures that were all related 
to ACh synapses, the initial comparisons were 
conducted by a global analysis of variance 
(ANOVA; data log-transformed because of 
heterogeneous variance among regions and 
measures) incorporating all the variables and 
measurements in order to avoid an increased 
probability of type 1 errors that might other-
wise result from multiple tests of the same data 
set. The variables in the global test were treat-
ment (control, parathion 0.1 mg/kg, parathion 
0.2 mg/kg), diet (normal, high-fat), brain 
region, sex, and measure (nAChR binding, 
ChAT, HC3 binding); the latter was consid-
ered a repeated measure because all three deter-
minations were derived from the same sample. 
Where we identified interactions of treatment 
with the other variables, data were then sub-
divided for lower-order ANOVAs to evaluate 
treatments that differed from the corresponding 
control. Where permitted by the inter  action 
terms, individual groups that differed from 
control were identified with Fisher’s protected 
least significant difference test. Significance was 
assumed at the level of p < 0.05.
To ensure that treatment and diet effects 
could be compared across all groups, we con-
ducted all three assays simultaneously on all 
samples for a given region and sex, but tech-
nical limitations dictated that each region 
and sex had to be performed in divided runs. 
Accordingly, the control values for region ver-
sus region or for males versus females cannot 
be compared directly, since each region was 
assayed separately, as was each sex. However, 
treatment and diet effects and their interactions 
with region and sex can be interpreted because 
these depend solely on the internal comparison 
to the matched control groups that were run 
together. In evaluating the magnitude of the 
changes elicited by parathion administration, 
we used entire brain regions rather than specific 
nuclei, which means that even drastic effects 
on a specific population of neurons show up as 
smaller changes due to dilution with unaffected 
areas. Despite this limitation, we found statisti-
cally significant alterations for both treatment 
paradigms in multiple regions.
Results
The global ANOVA identified a main effect 
of parathion treatment (p < 0.0001) as well as 
interactions of treatment with all the other vari-
ables: p < 0.01 for treatment × sex, p < 0.0001 
for treatment × ACh measure, p < 0.007 for Slotkin et al.
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treatment × sex × diet, p < 0.05 for treatment 
× diet × region, p < 0.002 for treatment × sex × 
ACh measure, p < 0.05 for treatment × region 
× ACh measure, p < 0.0001 for treatment × sex 
× diet × ACh measure, p < 0.006 for treatment 
× diet × region × ACh measure, and p < 0.05 
for treatment × sex × diet × region × ACh 
measure. In light of these interactions and of 
previous findings of strong sex differences in 
the effects of neonatal parathion exposure on 
neuro  development (Lassiter et al. 2008; Slotkin 
et al. 2008b, 2009), we also conducted a low-
er-order test separately for males and females. 
Again, parathion treatment interacted with 
each of the other variables, but on the whole, 
the effects in males were more statistically 
robust than those in females (males: p < 0.0001 
for the main effect of treatment, p < 0.0001 for 
treatment × ACh measure, p < 0.02 for treat-
ment × diet, p < 0.03 for treatment × region, 
p < 0.01 for treatment × diet × ACh measure, 
p < 0.002 for treatment × diet × region × ACh 
measure; females: p < 0.0002 for treatment × 
diet × ACh meas  ure, p < 0.002 for treatment 
× diet × region × ACh measure). As required 
by these inter  actions, we then separated the 
results according to region, diet, sex, and ACh 
measure for presentation.
For the control group, the high-fat diet 
alone had no statistically significant effect 
on any of the measures when evaluated in a 
global test (factors of diet, sex, region, ACh 
measure) or separately for each of the meas-
ures. Accordingly, where apparent changes are 
caused by diet alone in the control group, the 
overall incidence of such “differences” can-
not be distinguished from random; indeed, 
in the global ANOVA, we found no main 
effect of diet or interaction of diet × region 
(exclusive of the interactions with parathion 
treatment) for males or females for any of the 
variables. Further, because binding affinity can 
be influenced by the lipid milieu in which the 
proteins are embedded (Gudbjarnason and 
Benediktsdottir 1996; Ponsard et al. 1999), the 
effects of parathion must be compared to the 
corresponding, diet-matched control group, 
whereas interpreting apparent differences in 
the two control groups is problematic.
Parathion had differential effects on the 
ACh measures in the various brain regions 
of males and females, and most of these were 
reversed by the high fat diet. In the frontal/
parietal cortex, neonatal parathion exposure 
had little or no effect on nAChR binding in 
males, regardless of whether animals were con-
suming a normal or high-fat diet (Figure 1A). 
In females, parathion evoked a dose-dependent 
decrement in frontal/parietal cortical nAChR 
binding that was completely reversed by a 
high-fat diet. For ChAT activity in   frontal/
parietal cortex, males showed significant 
reductions at either parathion dose; again, the 
high-fat diet reversed the defects (Figure 1B). 
In females, neo  natal parathion exposure elic-
ited substantial increases in ChAT in the same 
region; in this case, the high-fat diet com-
pletely reversed the pattern, such that animals 
exposed to 0.2 mg/kg parathion exhibited 
significantly lower values than controls. For 
HC3 binding in the frontal/parietal cortex, 
neonatal parathion exposure caused significant 
reductions in both males and females, whereas 
animals on a high-fat diet did not display any 
deficits (Figure 1C). In the temporal/occipital 
cortex, neonatal parathion exposure elicited 
significant reductions in nAChR binding in 
males on the normal diet but not in those on 
the high-fat diet; we saw no parathion effects 
in females on either diet (Figure 1D). Also in 
this region we observed no significant changes 
in ChAT with parathion alone or in combi-
nation with a high-fat diet (Figure 1E). For 
HC3 binding in the temporal/occipital cortex, 
males showed a significant reduction caused by 
neonatal parathion; however, for this param-
eter, the high-fat diet provided no protection 
(Figure 1F); females showed no significant 
effects on HC3 binding.
In the hippocampus, males exposed to 
the high dose of parathion displayed signifi-
cant elevations in nAChR binding that were 
reversed by the high-fat diet (Figure 2A); 
females showed no significant effects of para-
thion in either dietary group. In animals con-
suming a normal diet, hippocampal ChAT 
was significantly reduced at both doses in 
males and at the low dose in females, but no 
such changes were seen on the high-fat diet 
(Figure 2B). In contrast, hippocampal HC3 
binding was unaffected by parathion with or 
without a high-fat diet (Figure 2C). In the 
striatum, nAChR binding was unaffected by 
parathion exposure (Figure 2D). However, for 
striatal ChAT, parathion evoked significant 
reductions in males but not females, and the 
Figure 1. Effects of neonatal parathion exposure (0.1 or 0.2 mg/kg) and subsequent adult consumption of a 
high-fat diet on ACh synaptic parameters in the frontal/parietal cortex (A–C) and temporal/occipital cortex 
(D–F). (A, D) nAChR binding. (B, E) ChAT activity. (C, F) HC3 binding to the presynaptic high-affinity choline 
transporter. Data represent mean ± SE obtained from six rats per group. ANOVA for each cluster appears 
within the panels. NS, not significant. 
*Individual values for which the parathion groups differ from the corresponding diet-matched control.
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high-fat diet was unable to reverse the effect 
(Figure 2E). Striatal HC3 binding evinced no 
significant differences (Figure 2F).
In the midbrain, males on the normal 
diet showed a significant parathion-induced 
reduction in nAChR binding that was not seen 
in animals on the high-fat diet (Figure 3A); 
females showed no significant effects. For mid-
brain ChAT, both sexes showed significant 
reductions evoked by neonatal parathion expo-
sure, involving the high dose for males and the 
low dose for females (Figure 3B); the high-fat 
diet eliminated both defects. Midbrain HC3 
binding was generally unaffected by parathion 
(Figure 3C). In the brainstem, neonatal para-
thion exposure evoked nAChR up-regulation 
restricted to males, and once again, the high-fat 
diet completely reversed the effect (Figure 3D). 
In contrast, parathion-exposed females but not 
males showed elevated ChAT (Figure 3E) and 
suppressed HC3 binding (Figure 3F) in the 
brainstem, and both of these effects were offset 
by the high-fat diet.
We presented the effects of parathion treat-
ments and dietary manipulations on body 
weights in this model previously (Lassiter et al. 
2008); because we used animals from the same 
cohort in the present study, the results are not 
presented here. In brief, parathion alone pro-
duced a small (2–3%) but significant elevation 
in weight at the low dose in males and reduc-
tions of about 4% at either dose in females. 
The high-fat diet alone produced significant 
increases in body weight for both males (10% 
increase) and females (30% increase). In males, 
neonatal parathion treatment did not affect the 
body weight response to high fat, whereas the 
dietary effect was diminished at the high para-
thion dose in females.
Discussion
Our results clearly indicate that consuming 
a high-fat diet in adulthood can ameliorate 
many of the long-term ACh synaptic abnor-
malities evoked by neonatal parathion expo-
sure. We assessed three ACh measures for each 
of six brain regions, for a total of 18 sets of 
determinations for each sex. In males, para-
thion exposure evoked significant changes 
in 10 of these measures, of which 8 were 
reversed by the high-fat diet; in females, 7 of 
the measures were affected, and all of them 
were reversed by dietary manipulation, albeit 
that one measure then became abnormal in 
the opposite direction (ChAT in the frontal/ 
parietal cortex). These findings provide a proof 
of principle that dietary interventions are 
capable of offsetting the ACh synaptic defects 
caused by developmental neuro  toxicant expo-
sure; future studies clearly need to address 
whether behavioral performance is similarly 
restored by dietary manipulation, as is the case 
for anomalies evoked by genetic manipulations 
(Teegarden et al. 2008).
Our results thus open a new avenue for 
developing general amelioration strategies that 
may prove useful for diffuse and diverse neuro-
toxicants. Obviously, the use of a high-fat diet 
poses serious metabolic problems that may pre-
clude its generalized use. Indeed, in our earlier 
work, we showed that neonatal exposure to 
organophosphates evokes long-term changes in 
metabolic function that contribute to obesity, 
prediabetes, and cardio  vascular risk factors such 
as elevated serum lipids (Lassiter and Brimijoin 
2008; Lassiter et al. 2008; Roegge et al. 2008; 
Slotkin et al. 2005). The metabolic abnormali-
ties were exacerbated by a high-fat diet (Lassiter 
et al. 2008; Roegge et al. 2008). It will there-
fore be important to establish whether there are 
specific components of the diet that are the key 
elements responsible for the reversal of ACh 
synaptic abnormalities that may permit use of a 
less injurious dietary manipulation.
Nevertheless, the effects of parathion on 
ACh systems comprise an alteration in the 
“trajectory” of ACh synaptic development 
and function, rather than representing an 
outright initial injury that simply continues 
into adulthood. Indeed, none of these syn-
aptic changes is apparent in the immediate 
post  treatment period (Slotkin et al. 2006a); 
instead, the effects emerge over an extended 
time frame ranging from adolescence to adult-
hood (Slotkin et al. 2008b, 2009). This means 
that there may be specific developmental 
“windows” in which a short-term interven-
tion can redirect the trajectory of ACh synap-
tic develop  ment, thus avoiding the need for 
life-long intervention. Again, this will be an 
important subject for future studies.
The results of the present study also con-
firm and extend earlier work on the develop-
mental neuro  toxicity of parathion that 
indicated sex-selectivity and regional differ-
ences in the effects on ACh systems as well 
as other neuro  transmitters (Slotkin et al. 
2008b, 2009). Developmental exposure to 
Figure 2. Effects of neonatal parathion exposure (0.1 or 0.2 mg/kg) and subsequent adult consumption of a 
high-fat diet on ACh synaptic parameters in the hippocampus (A–C) and striatum (D–F). (A, D) nAChR binding. 
(B, E) ChAT activity. (C, F) HC3 binding to the presynaptic high-affinity choline transporter. Data represent mean 
± SE obtained from six rats per group. ANOVA for each cluster appears within the panels. NS, not significant. 
*Individual values for which the parathion groups differ from the corresponding diet-matched control. 
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organophosphates commonly elicits highly 
sex-dependent alterations at the synaptic and 
behavioral levels (Aldridge et al. 2004, 2005; 
Dam et al. 2000; Levin et al. 2001, 2002; 
Moser et al. 1998; Ricceri et al. 2006; Roegge 
et al. 2008; Slotkin et al. 2001a, 2002, 
2006b, 2008a, 2008c; Slotkin and Seidler 
2005, 2007; Timofeeva et al. 2008a) because 
of interference with sexual differentiation of 
the brain (Aldridge et al. 2005; Levin et al. 
2001; Slotkin 1999, 2004, 2005). However, 
in comparing our results in the present study 
at 5 months of age to those seen in adoles-
cence (1 month of age) or young adulthood 
(2–3 months of age) (Slotkin et al. 2008b), 
we observed that many of the sex-selective 
differences intensified with time. This is con-
sonant with the fact that, even where an ini-
tial injury might be equivalent in males and 
females, subsequent repair processes are gen-
erally greater in females, thus contributing 
to even further differences in the trajectory 
of ACh synaptic development and function 
(Amateau and McCarthy 2002; Hilton et al. 
2004; McEwen 2002; Nunez and McCarthy 
2003; Slotkin et al. 2007b; Tanapat et al. 
1999). Similar effects are likely to play a role 
in the fact that the high-fat diet successfully 
reversed all of the parathion-induced changes 
in females, whereas some of the abnormalities 
persisted in males.
As in a number of earlier studies of the 
effects of developmental organophosphate 
exposure (Levin et al. 2002; Slotkin et al. 
2008a; Timofeeva et al. 2008a), we found 
some effects of parathion that were non-
monotonic, with significant alterations at the 
low dose but not at the high dose (ChAT 
in female hippocampus and midbrain, HC3 
binding in female brainstem). This likely 
represents the fact that the higher dose of 
parathion elicits some systemic toxicity 
(Slotkin et al. 2006a), which will by itself 
produce additional changes in ACh function. 
Additionally, cholinesterase inhibition at the 
higher dose can provide a positive trophic 
effect by increasing the levels of ACh in the 
developing brain (Hohmann 2003; Lauder 
and Schambra 1999; Picciotto and Zoli 2008; 
Slotkin et al. 2006b). Indeed, a carefully cho-
sen, small dose of chlorpyrifos can actually 
enhance some aspects of neuro  development 
while damaging other components (Laviola 
et al. 2006). In the present study, the high-
fat diet reversed the anomalies regardless of 
whether they were non  monotonic or mono-
tonic, so the presence or absence of these 
additional components does not appear to 
be critical to the ameliorating effect of dietary 
manipulation.
Finally, results of the present study point 
to an important consideration in the explosive 
worldwide increase in obesity. It is clear that 
neuro  developmental disorders can influence 
apparent life  style choices, most notably in the 
increased incidence of drug abuse or cigarette 
smoking (Deas and Brown 2006; Kandel et al. 
1994; Pliszka and Pliszka 2003; Weissman 
et al. 1999; Wilens 2004). In a recent study 
Jacobsen et al. (2007) showed that abstinence 
from smoking in adolescent smokers whose 
mothers smoked during pregnancy leads to 
cognitive impairment, whereas those who 
were born to non  smokers showed cognitive 
improvement upon abstinence from smoking. 
In other words, where there was pre  existing 
neuro  developmental damage from prenatal 
tobacco exposure, adolescents were able to 
offset cognitive impairment by smoking; this 
likely contributes to the higher likelihood of 
the children born to smoking women becom-
ing smokers themselves (Kandel et al. 1994; 
Weissman et al. 1999). By the same token, our 
studies point to the possibility that exposure to 
develop  mental neuro  toxicants could contribute 
to a subsequent preference for a high-fat diet as 
a way of ameliorating the effects, thus provid-
ing an indirect but potentially potent driving 
force for consuming an unhealthy diet. If this 
turns out to be true, then our findings point to 
a potentially important contributory factor in 
the increased incidence of obesity and diabe-
tes, expanding the public health implications 
of the “silent pandemic” caused by develop-
mental neurotoxicant exposure (Grandjean 
and Landrigan 2006).
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